Table 1

Phenotypic characteristics of patients with collagen-binding mutations

p.S1731Tp.W1745Cp.S1783Ap.H1786D
No. of patients 
Bleeding score* 0-2 4-8 5-10 
VWF:Ag, IU/dL 0.30-0.75 0.29-0.52 0.68-0.88 0.41 
VWF:RCo, IU/dL 0.30-0.64 0.27-39 0.57-0.66 0.44 
CB:Ag ratio 0.4-0.9 0.1-0.3 0.2-0.4 0.5 
Multimers Normal Normal Normal Normal 
References 16 17 17 15 
p.S1731Tp.W1745Cp.S1783Ap.H1786D
No. of patients 
Bleeding score* 0-2 4-8 5-10 
VWF:Ag, IU/dL 0.30-0.75 0.29-0.52 0.68-0.88 0.41 
VWF:RCo, IU/dL 0.30-0.64 0.27-39 0.57-0.66 0.44 
CB:Ag ratio 0.4-0.9 0.1-0.3 0.2-0.4 0.5 
Multimers Normal Normal Normal Normal 
References 16 17 17 15 

All of the subjects included were heterozygous for the collagen-binding mutation, except 1 of the p.W1745C subjects who was compound heterozygous for a second missense mutation associated with type 1 VWD (p.R760H).

*

The condensed MCMDM-1 and original MCMDM-1 questionnaires were used.18,19  A score of ≥4 is abnormal.

A bleeding score was only available for 4 of 6 of these subjects.

or Create an Account

Close Modal
Close Modal